Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.54 |
| ▸ | TPH1 | P17752 | 12/20 | 0.49 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.47 |
| ▸ | ACACB | O00763 | 1/20 | 0.46 |
| ▸ | CTSC | P53634 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | FEN1 | P39748 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | TPH2 | Q8IWU9 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3627309 | 0.89 | SLC13A5 (0.50) | SLC13A5ACACBCTSCFEN1FFAR1 | |
| SCHEMBL3627307 | 0.89 | SLC13A5 (0.50) | SLC13A5ACACBCTSCFEN1FFAR1 | |
| SCHEMBL31688626 | 0.88 | GRIA2 (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL539411 | 0.88 | SLC13A5 (0.49) | SLC13A5ACACBCTSCFEN1FFAR1 | |
| SCHEMBL25357821 | 0.85 | LOX (0.55) | SLC7A5ACACBALPIPKMPTGS1 | |
| SCHEMBL31747001 | 0.85 | LOX (0.55) | SLC7A5ACACBALPIPKMPTGS1 | |
| SCHEMBL14861107 | 0.85 | LOX (0.55) | SLC7A5ACACBALPIPKMPTGS1 | |
| SCHEMBL12001654 | 0.80 | ACACB (0.70) | SLC13A5ACACB | |
| SCHEMBL2005412 | 0.79 | TPH1 (0.69) | TPH1SLC7A5ALPIPKMPTGS1 | |
| SCHEMBL31369944 | 0.79 | TPH1 (0.54) | TPH1SLC7A5TPH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | SLC13A5 1155/4885TPH1 3558/4885SLC7A5 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.